Latest Health News

Trading in Alliance Aviation Services Limited (AQZ) shares has resumed following the lifting of a suspension tied to a recent trading update announcement.

The Calmer Co. International Limited announces a leadership change with James S. Tonkin appointed Chairman as the company accelerates its U.S. market growth in natural kava products.

MedAdvisor Limited has appointed John Ciccio as its new CEO and Managing Director, marking a strategic leadership shift aimed at capitalising on recent technology advancements and US market growth.

Proteomics International secures half a million dollars from the Western Australian Government to accelerate commercialisation of PromarkerEndo, a groundbreaking blood test for early endometriosis diagnosis.

Group 6 Metals has materially improved its debt position by converting warrants under its April 2025 recapitalisation plan, signaling renewed shareholder confidence and operational momentum.

Eden Innovations has completed the sale of its Georgia property for US$5 million, using the proceeds to significantly reduce its debt and edge closer to completing its financial reconstruction.

Bentley Capital Limited is poised to lift its trading suspension on 6 November 2025 following a key announcement addressing legal costs and regulatory queries.

Cleo Diagnostics has identified a significantly larger U.S. patient population for its pre-surgical ovarian cancer test, expanding its commercial opportunity ahead of next year’s market entry.

Noumi Limited reported a 13% rise in adjusted operating EBITDA for FY25, driven by strong growth in its Milklab plant-based milk brand, while preparing for a significant convertible note maturity in 2027.

Amcor’s first quarter fiscal 2026 results showcase strong growth driven by the Berry Global acquisition, with sales up 68% and synergies exceeding expectations. The company also raised its dividend and reaffirmed its full-year guidance.

Larvotto Resources has appointed PYBAR Mining Services to undertake extensive underground development at its Hillgrove Antimony-Gold Project, paving the way for production to commence in 2026.

National Australia Bank reported a modest rise in underlying profit for FY25, driven by robust revenue and volume growth in the second half, alongside continued technology modernization and sustainability progress.